Should donor livers with marked steatosis be used for transplantation;Sollten spenderlebern mit ausgepragter steatose zur transplantation verwendet werden?

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 14, Issue 4, 1998, Pages 323-328

  Canelo, R ^a   Braun, F ^a   Sattler, B ^a   Ringe, B ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Donor criteria; Liver cell necrosis; Liver transplantation; Primary non dysfunction; Steatotic liver

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FATTY LIVER; FEMALE; GRAFT FAILURE; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; RISK ASSESSMENT; SCHOOL CHILD; SCREENING;

EID: 0032412296     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012516     Document Type: Article

References (25)

1. Mor E, Klintmaln GB, Gonwa TA, et al: The use of marginal donors for liver transplantation. Transplantation 1992;53:383-386.
2. Karayalcin K, Darius FN, Harrison RF, et al: The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 1994;57:1323-1327.
3. Bilbao I, Charco R, Hidalgo E, et al: Risk factors of severe ischemic injury after liver transplantation. Transplant Proc 1997;29:368-370.
4. Shayeb J, Plevak D, Rettke S, et al: Predictors of primary nonfunction: Is donor liver fat content important? Transplant Proc 1993;25:1974.
5. Trevisani F, Colantoni A, Caraceni P, van Thiel DH: The use a donor fatty liver for liver transplantation: A challenge or a quagmire? J Hepatol 1996;24:114-121.
6. Agnes S, Avolio AW, Magalini SC, Grieco G, Castagneto M: Marginal donors for patients on regular waiting list for liver transplantation. Transplant Int 1996;9:469-471.
7. Ricci C, Longo R, Gioulis E, et al: Non-invasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
8. Fukimori T, Ohkohchi N, Sansalone CV, et. al: Why is a fatty liver insuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during could preservation of a liver with steatosis. Transplant Proc 1997;29:412-415.
9. Siddiqui MT, Reddy WB, Castelli MJ, Gattuso P: Role of fine needle aspiration in clinical management of transplant patients. Diagn Cytopathol 1997;17:429-435.
10. Haller GW, Langrehr JM, Bumhardt G, Platz KP, Müller A: Factors relevant to the development of primary dysfunction in liver allografts. Transplantation 1995;27:1192.
11. De Carlis L, Sansalone CV, Rondinara GF, et al: Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria. Transplant Int 1996;9:414-417.
12. 1. Results in increased graft and patient survival. Transplant Proc 1989;21:2385-2388.
13. Gubernatis G, Tusch G, Ringe B, Bunzendahl H, Pichlmayr R: Score-aided decision making in patients with severe liver damage after hepatic transplantation. Worl J Surg 1989;13:259-265.
14. Ringe B, Braun F, Lorf T: Liver Transplantation (in press).
15. Oellerich M, Burdelski M, Ringe B, et al: Lignocaine metabolite formation as a measure pretransplant liver function. Lancet 1989;i:640-642.
16. Yamaoka Y, Washida M, Manaka D, et al: Arterial ketone body ratio as a predicting factor of donor liver viability in human transplantation. Transplantation 1993;55:92-95.
17. Matesanz R, Miranda B: Need for liver transplantation. Lancet 1995;346:1168-1169.
18. D'Alessandro AM, Klayoglu M, Sollinger HW, et al: The predictive value of donor liver biopsy for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 1991;51:157-163.
19. Loh YH, Dunn GD: Diffuse fatty infiltration of the liver: Pitfalls in computed tomography diagnosis. Australas Radiol 1997;41:383-386.
20. Todo S, Demetris AJ, Teperman L, et al: Primary non function of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 45:903-905.
21. Teramoto K, Bowers JL, Kruskal JB, et al: Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation 1993;56:1076-1082.
22. Cywes R, Mullen M, Stratis M, et al: Prediction of the outcome of transplantation in man by platelet adherence in donor liver allograft. Transplantation 1993;56:316-323.
23. Husberg BS, Genyk YS, Klintmaln GB, et al: A new rat model for studies of the ischemic injury after transplantation of fatty livers: Improvement after postoperative administration of prostaglandin. Transplantation 1994;57:457-458.
24. Molloy RM, Komorowski R, Varma RR: Recurrent non-alcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transplant Surg 1997;3:177-178.
25. Colina F, Lopez-Carreira M, Moreno E, et al: A clinicopathologic review of 8 liver graft primary nonfunctions. Hepatotogastroenterology 1995; 42:212-221.